Ubie
Founded Year
2017Stage
Incubator/Accelerator - III | AliveTotal Raised
$115.35MRevenue
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+3 points in the past 30 days
About Ubie
Ubie provides symptom-checking and disease prediction services. The company offers a web-based platform that includes health reports, causes of symptoms, and treatment information developed by medical professionals. Its AI system customizes questions based on the user's biological sex, age, and health history. It was founded in 2017 and is based in Tokyo, Japan.
Loading...
ESPs containing Ubie
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The symptom assessment & triage platforms market utilizes digital tools to help patients assess symptoms and determine the appropriate level of care. These solutions can help reduce the burden on high-acuity and emergency services, improve access to reliable clinical advice 24/7, streamline patient journeys, increase provider productivity and quality, and save money by directing patients to the le…
Ubie named as Highflier among 14 other companies, including K Health, Ada Health, and GYANT.
Ubie's Products & Differentiators
Ubie AI Health Assistant
Ubie AI Health Assistant is a medical interview service that uses tablets and smartphones in place of medical institutions' paper interview sheets to improve medical institutions' work efficiency. By utilizing the translated interview content and the results of the disease name dictionary, physicians can significantly reduce the clerical work required to complete the electronic medical records and concentrate on examining patients. When patients enter their symptoms at medical institutions using tablets, they can take advantage of the waiting time before seeing a doctor and convey the details of their symptoms in advance. As of January 2022, it has been introduced in more than 500 medical institutions in 47 prefectures across Japan.
Loading...
Research containing Ubie
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Ubie in 4 CB Insights research briefs, most recently on Apr 17, 2025.
Apr 17, 2025 report
State of Digital Health Q1’25 Report
Jan 11, 2024
The generative AI in healthcare market map
Expert Collections containing Ubie
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Ubie is included in 3 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
12,580 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
11,422 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,122 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Latest Ubie News
Sep 5, 2025
日本赤十字社愛知医療センター名古屋第二病院、「ユビー生成AI」導入 2025年9月5日 11時00分 Ubie株式会社（本社：東京都中央区、共同代表取締役：阿部吉倫・久保恒太、以下「Ubie」）が提供する、生成AIで生産性向上を図るサービス「ユビー生成AI」が、日本赤十字社愛知医療センター名古屋第二病院（所在地：愛知県名古屋市、以下「名古屋第二病院」）にて導入され、院内業務での利用が開始されました。導入開始後、すでに800名を超える医療従事者がモバイル端末・PCにて活用し、院内の幅広い業務効率化を目指しています。なお、「ユビー生成AI」の導入は赤十字病院で初となります。 ■取り組み背景と導入目的 日本赤十字社愛知医療センター名古屋第二病院は、日本最大級の医療事業を有する日本赤十字社の中でも有数の病床規模を誇り、地域医療支援病院として愛知県の地域医療を支える重要な役割を担っています。同院は、かねてより医療DX推進に積極的に取り組んでおり、特に医療文書作成における業務負担の軽減は喫緊の課題でした。 こうした背景のもと、さらなる業務効率化と医療従事者の負担軽減を目指し、幅広いユースケースと導入実績を評価して「ユビー生成AI」の導入を決定いたしました。 ■活用事例 名古屋第二病院では、「ユビー生成AI」の導入により、医療文書作成業務の効率化と医療従事者の負担軽減を推進しています。特に、同院が独自に構築したDWHから情報を取得するツールを活用することで、電子カルテ内の情報を生成AIに与える工程の負担軽減を図っています。今回の導入により、同院で稼働する電子カルテシステム（富士通製：HOPE LifeMark-HX）環境下で「ユビー生成AI」が機能することを確認できました。また、PCのみならず院内ネットワーク経由でモバイル端末からも利用可能とすることで、医療従事者が場所を選ばずに業務効率化を図れる環境を構築し、すでに800名を超える医療従事者が利用しています。 ■今後の展望 ■日本赤十字社愛知医療センター名古屋第二病院 医療DXセンター ICT室長 錦見 俊徳 様 当院ではこれまでも、医療DXに積極的に取り組んでまいりました。今回、ユビー生成AIを導入し、当院医療情報管理センターの協力のもと、既存システムとの連携や富士通HX環境下で安定稼働を確認できたことは大きな成果です。医師の退院サマリーや紹介状の文字起こし、看護師の情報収集やサマリー、事務の議事録作成等、各現場の様々な用途で使用を開始しています。導入初月の段階で800名を超える職員が利用するなど、現場の関心も高く、今後も現場主導で活用を推進し、病院全体の業務効率化と医療の質の向上を目指します。 ■お問い合わせ
Ubie Frequently Asked Questions (FAQ)
When was Ubie founded?
Ubie was founded in 2017.
Where is Ubie's headquarters?
Ubie's headquarters is located at 3-8-4 Nihonbashi Honcho, Chuo-ku, Tokyo.
What is Ubie's latest funding round?
Ubie's latest funding round is Incubator/Accelerator - III.
How much did Ubie raise?
Ubie raised a total of $115.35M.
Who are the investors of Ubie?
Investors of Ubie include Mayo Clinic Platform Accelerate, Shoko Chukin Bank, Google Cloud Next, Seven & I Holdings, NTT DoCoMo and 23 more.
Who are Ubie's competitors?
Competitors of Ubie include Docus and 1 more.
What products does Ubie offer?
Ubie's products include Ubie AI Health Assistant and 3 more.
Who are Ubie's customers?
Customers of Ubie include Takeda General Hospital.
Loading...
Compare Ubie to Competitors
Therapha is a technology company focused on providing clinical decision support and musculoskeletal triaging through an AI-enabled platform. The company offers a conversational chatbot that assists healthcare providers by analyzing patient-reported symptoms and medical history to suggest possible diagnoses and streamline documentation. Therapha's solutions are designed to integrate into clinical workflows, enhance patient engagement, and support telehealth services. It was founded in 2019 and is based in New York, New York.
Infermedica specializes in automating primary care through its medical guidance platform and operates within the healthcare technology sector. The company offers a suite of intelligent healthcare technologies for early symptom assessment, digital triage, and facilitating communication between physicians and patients. Infermedica primarily sells to sectors such as insurers, public health and government, healthcare providers, and telemedicine companies. It was founded in 2012 and is based in Wroclaw, Poland.
Health Note focuses on improving the healthcare experience through technology and operates within the healthcare technology industry. The company offers a clinically intelligent patient intake system that automates the updating of electronic health records (EHR) and the creation of clinical notes, reducing the workload for healthcare providers. Its services primarily cater to the healthcare industry. It was founded in 2018 and is based in San Francisco, California.
SOAP Health specializes in using conversational and generative AI within the healthcare sector to streamline patient intake and clinical documentation. The company offers solutions that automate the collection and analysis of clinical data, integrate seamlessly with electronic health records (EHRs), and assist in risk assessment and preventive healthcare. SOAP Health's products are designed to save time for healthcare providers, enhance revenue, and reduce malpractice exposure while ensuring regulatory compliance. SOAP Health was formerly known as GeneYes. It was founded in 2019 and is based in Boca Raton, Florida.
Doctronic provides health assistance services within the digital healthcare domain. Its main offerings include analysis of health issues, symptom exploration, and personalized health information, which support interactions between patients and healthcare providers. The company serves individuals seeking healthcare solutions. It was founded in 2023 and is based in New York, New York.
OpenEvidence specializes in the aggregation and analysis of medical knowledge using artificial intelligence. The company offers a platform that synthesizes and visualizes clinical evidence to support evidence-based decision-making in medicine. OpenEvidence primarily caters to healthcare professionals, including physicians and medical scientists, by providing access to analyzed and synthesized medical literature. It was founded in 2021 and is based in Cambridge, Massachusetts.
Loading...